Validation of a novel score to predict which patients with atrial fibrillation and depressed left ventricular ejection fraction will respond to catheter ablation

Serban, Teodor; Lavallaz, J Du Fay De; Barker, David Charles; Sticherling, Christian; Kühne, Michael; Badertscher, Patrick

doi:10.1016/j.rec.2023.03.014

Cited by 2 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Antwerp score has been recently proposed to identify AICM patients from a population with depressed LVEF undergoing CA for AF showing variable predictive power in different populations. 16 , 17 , 22 According to the current questionnaire, as only a very small number 21 (10%) of the respondents chose all four proposed parameters as predictors for LVEF recovery after CA for AF, we report that the awareness for this predictive model is currently very low. This tool, however, requires prospective validation.…”

Section: Discussionmentioning

confidence: 93%

“…This divergence underscores the lack of standardized follow-up duration and calls for research to optimize monitoring periods. 16 , 17 , 22 , 33 , 34 …”

Section: Discussionmentioning

confidence: 99%

“… 11–15 Recently, a novel predictive model attempted an early identification of LVEF recovery after CA for atrial fibrillation (AF). 16 , 17 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey

Serban,

Badertscher,

du Fay de Lavallaz

et al. 2024

Europace

View full text Add to dashboard Cite

Background Arrhythmia-induced Cardiomyopathy (AiCM) represents a subtype of acute heart failure (HF) in the context of sustained arrhythmia. Clear definitions and management recommendations for AiCM are lacking. Purpose The European Heart Rhythm Association Scientific Initiatives Committee (EHRA SIC) conducted a survey to explore the current definitions and management of patients with AiCM among European and non-European electrophysiologists. Methods A 25-item online questionnaire was developed and distributed among EP specialists on the EHRA SIC website and on social media between September 4th and October 5th 2023. Results Of the 206 respondents, 16% were female and 61% were between 30-49 years old. Most of the respondents were EP-Specialists (81%) working at University Hospitals (47%). While most participants (67%) agreed that AiCM should be defined as a left ventricular ejection fraction (LVEF) impairment after new onset of an arrhythmia, only 35% identified a specific LVEF drop to diagnose AiCM with a wide range of values (5-20% LVEF drop). Most respondents considered all available therapies: catheter ablation(93%), electrical cardioversion(83%), antiarrhythmic drugs (76%) and adjuvant HF treatment(76%). 83% of respondents indicated that adjuvant HF treatment should be started at first HF diagnosis prior to antiarrhythmic treatment and 84% agreed it should be stopped within six months after LVEF normalization. Responses for the optimal time point for the first LVEF reassessment during follow-up varied markedly (1 day-6 months after antiarrhythmic treatment). Conclusion This EHRA Survey reveals varying practices regarding AiCM among physicians, highlighting a lack of consensus and heterogenous care of these patients.

show abstract

Section: Discussionmentioning

confidence: 93%

“…This divergence underscores the lack of standardized follow-up duration and calls for research to optimize monitoring periods. 16 , 17 , 22 , 33 , 34 …”

Section: Discussionmentioning

confidence: 99%